D
41
4
BLK
61
-5
VIX
25
3
CSCO
60
-4
CAT
70
-9
CVX
25
-4
CVS
39
-11
AMAT
49
-6
ABT
41
3
AMZN
50
-5
ETR
52
-2
AA
67
-5
CMCSA
42
8
CCI
42
-2
COF
65
-3
CMI
72
-5
EMN
62
-3
CA
21
-6
AEP
59
-2
CCL
65
-3
D
41
4
BLK
61
-5
VIX
25
3
CSCO
60
-4
CAT
70
-9
CVX
25
-4
CVS
39
-11
AMAT
49
-6
ABT
41
3
AMZN
50
-5
ETR
52
-2
AA
67
-5
CMCSA
42
8
CCI
42
-2
COF
65
-3
CMI
72
-5
EMN
62
-3
CA
21
-6
AEP
59
-2
CCL
65
-3
Financhill
Back

First Trust Large Cap Growth AlphaDEX Fund Vs. Summit Therapeutics, Inc. Industry Stock Comparison

Buy
57

FTC
First Trust Large Cap Growth AlphaDEX Fund

Last Price:
$162.03
Seasonality Move:
4.93%
Sell
36

SMMT
Summit Therapeutics, Inc.

Last Price:
$17.57
Seasonality Move:
8.83%
Buy
57
First Trust Large Cap Growth AlphaDEX Fund (FTC) is a Buy

Is First Trust Large Cap Growth AlphaDEX Fund a Buy, Sell or Hold?

  • The current First Trust Large Cap Growth AlphaDEX Fund [FTC] share price is $160.11. The Score for FTC is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • FTC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Summit Therapeutics, Inc. (SMMT) is a Sell

Is Summit Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Summit Therapeutics, Inc. [SMMT] share price is $17.57. The Score for SMMT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FTC Stock Price Chart

What is First Trust Large Cap Growth AlphaDEX Fund's stock price today?

  • The First Trust Large Cap Growth AlphaDEX Fund share price today is $160.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTC is experiencing selling pressure, which indicates risk of future bearish movement.

SMMT Stock Price Chart

What is Summit Therapeutics, Inc.'s stock price today?

  • The Summit Therapeutics, Inc. share price today is $17.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing slight selling pressure.

FTC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.91 Buy
Relative Strength Index (14 RSI): 51.35 Buy
Chaikin Money Flow: -2813 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (154.74 - 162.08) Buy
Bollinger Bands (100): (155.51 - 161.81) Buy

SMMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 46.35 Sell
Chaikin Money Flow: -689063 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.99 - 18.53) Sell
Bollinger Bands (100): (17.64 - 25.2) Sell

FTC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 161.34 Sell
20-day SMA: 157.85 Buy
50-day SMA: 159.84 Buy
200-day SMA: 148.81 Buy
8-day EMA: 161.01 Sell
20-day EMA: 159.74 Buy
50-day EMA: 156.01 Buy
200-day EMA: 98.17 Buy

SMMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.08 Sell
20-day SMA: 17.57 Buy
50-day SMA: 19.01 Sell
200-day SMA: 21.95 Sell
8-day EMA: 17.84 Sell
20-day EMA: 17.92 Sell
50-day EMA: 18.85 Sell
200-day EMA: 20.45 Sell

First Trust Large Cap Growth AlphaDEX Fund Earnings Growth & FTC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Summit Therapeutics, Inc. Earnings Growth & SMMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and an increase next year of $0.03 per share.

First Trust Large Cap Growth AlphaDEX Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Summit Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):